MetaCap

MoonLake Immunotherapeutics Statistics

NASDAQ: MLTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

11.07+0.04 (+0.36%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

MoonLake Immunotherapeutics by the numbers

MoonLake Immunotherapeutics has a market capitalization of $942.1 million based on 85.11M shares outstanding. With trailing EPS of $-3.66, MoonLake Immunotherapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 4.7% below its 50-day average and 31.5% below its 200-day average.

Average daily trading volume is 1.64M shares, or about $18.2 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

MLTX valuation vs. peer median

MLTX compared with the median of 8 peer companies
MetricMLTXPeer medianDifference
Market cap$942.13M$952.36M-1%
Avg. volume1.64M511.69K+221%

Peer median across 8 companies: SVRA, CYRX, SPTX, AKTS, OMER, LTGO, ANRO, MTRI.

Valuation

Price and trading

Previous close
11.03
Open
10.79
Day range
10.73 – 11.30
52-week range
9.46 – 23.29
52-week change
-12.63%
Beta
—
Volume
1.72M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
942.13M
Forward Pe
-3.26
Eps
-3.66
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
23.29
Week52 Low
9.46
Avg Volume
1.64M
Shares Outstanding
85.11M
Ma50
11.61
Ma200
16.16
Earnings Date
Nov 4, 2026
Pct From52w High
-52.47%
Pct From52w Low
17.02%

Related